Biophytis SA (BPTSY)
8.99
+1.49
(+19.87%)
USD |
OTCM |
May 07, 16:00
Biophytis Total Liabilities (Quarterly): 17.52M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.52M |
| June 30, 2023 | 19.53M |
| June 30, 2023 | 19.53M |
| December 31, 2022 | 25.63M |
| June 30, 2022 | 32.30M |
| June 30, 2022 | 32.30M |
| December 31, 2021 | 32.91M |
| June 30, 2021 | 35.42M |
| June 30, 2021 | 35.42M |
| December 31, 2020 | 30.68M |
| June 30, 2020 | 26.19M |
| Date | Value |
|---|---|
| June 30, 2019 | 19.85M |
| March 31, 2019 | 19.16M |
| June 30, 2018 | 6.515M |
| June 30, 2018 | 6.515M |
| December 31, 2017 | 5.709M |
| June 30, 2017 | 3.741M |
| June 30, 2017 | 3.741M |
| December 31, 2016 | 4.095M |
| June 30, 2016 | 3.266M |
| June 30, 2016 | 3.266M |
| December 31, 2015 | 2.125M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.52M
Minimum
Dec 2023
35.42M
Maximum
Jun 2021
27.27M
Average
28.43M
Median
Total Liabilities (Quarterly) Benchmarks
| Edap TMS SA | 38.27M |
| DBV Technologies SA | 42.80M |
| Cellectis SA | 249.58M |
| Genfit SA | 117.09M |
| Adaptimmune Therapeutics PLC | 243.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.22M |
| Shareholders Equity (Quarterly) | -4.264M |